“
We are proud to be featured in Boston University’s Research on Tap series, spotlighting the enduring legacy and ongoing impact of the Framingham Heart Study. This landmark longitudinal study — now spanning 78 years, three generations, more than 15,000 participants, and over 2 million biosamples — has fundamentally reshaped our understanding of cardiovascular disease and continues to drive […]
A Boston University-led research effort to advance our understanding and treatment of brain aging and Alzheimer’s disease has received a $31.5 million renewal of its funding. The Framingham Heart Study Brain Aging Program is one of the nation’s leading investigations into cognitive decline. The National Institute on Aging’s (NIA) five-year grant will provide the program’s primary operational […]
David Boas, Ji-Xin Cheng, Lindsay Farrer, Ed Kearns, and Xin Zhang join a select group that represents BU’s global leadership in research, education, and interdisciplinary collaboration When Lindsay Farrer received a cryptic email asking if he was available for a meeting with Boston University President Melissa Gilliam and Provost Colin Duckett, the only thing that […]
Matthew G. Nayor, MD, MPH, associate professor medicine at Boston University Chobanian & Avedisian School of Medicine, has been named medical director of the Framingham Heart Study (FHS). In this newly created position, Nayor will initially oversee and enhance the capture and adjudication of clinical events, including cardiovascular events, stroke, other major medical events and […]